Effects of lindane as an endocrine disruptor chemical on human health

Over the past decades, a number of substances in the environment have been detected to have detrimental effects on the endocrine system. These substances have been labeled as endocrine disruptor chemicals (EDC) as they mimic or block hormones function and therefore, disrupt the normal body physiolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Rozita, H.,, Hasni, M.J,
Format: Article
Language:English
Published: Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia 2005
Online Access:http://journalarticle.ukm.my/4457/1/vol11-02ayiesah.pdf
http://journalarticle.ukm.my/4457/
http://www.communityhealthjournal.org/detailarticle.asp?id=340&issue=Vol11(1):2005
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-ukm.journal.4457
record_format eprints
spelling my-ukm.journal.44572016-12-14T06:36:04Z http://journalarticle.ukm.my/4457/ Effects of lindane as an endocrine disruptor chemical on human health Rozita, H., Hasni, M.J, Over the past decades, a number of substances in the environment have been detected to have detrimental effects on the endocrine system. These substances have been labeled as endocrine disruptor chemicals (EDC) as they mimic or block hormones function and therefore, disrupt the normal body physiological functions. Effects on human beings include decrease in sperm counts and quality, cryptorchidism, hypospadias, testicular and male breast cancer,impairment of ovulatory mechanism and cardiovascular system. One of the examples of these EDC is lindane, a 99% pure gamma isomer of hexachlorocyclo-hexane. Exposures to lindane are either through dermal contact, inhalation or ingestion. Acute toxicity symptoms include headache, gastrointestinal symptoms, convulsion, cyanosis and circulatory collapse. Chronic symptoms include blood disorders, convulsion and disruption of the endocrine system particularly the reproductive system. Lindane has also been anticipated as a carcinogen. The International Agency for Research in Cancer (1991) has classified lindane as Class 2B carcinogen. The United States Environmental Protection Agency (USEPA) has set a maximum contaminant level of 0.2 parts per billion (ppb) in drinking water. Acceptable daily intake (ADI) for lindane by Codex Alimentarius is 0.001 mg / kg body weight per day. Due to its endocrine disruptor characteristic and carcinogen effects, there is a need for a rapid elimination of lindane usage in the pharmaceutical, veterinary and agricultural today. We also need an effective delivery of education programme about the risk of lindane, emphasizing the protection of exposed groups of children, indigenous people and workers. Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia 2005 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/4457/1/vol11-02ayiesah.pdf Rozita, H., and Hasni, M.J, (2005) Effects of lindane as an endocrine disruptor chemical on human health. Jurnal Kesihatan Masyarakat, 11 (1). pp. 51-55. ISSN 1675-1663 http://www.communityhealthjournal.org/detailarticle.asp?id=340&issue=Vol11(1):2005
institution Universiti Kebangsaan Malaysia
building Perpustakaan Tun Sri Lanang Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Kebangsaan Malaysia
content_source UKM Journal Article Repository
url_provider http://journalarticle.ukm.my/
language English
description Over the past decades, a number of substances in the environment have been detected to have detrimental effects on the endocrine system. These substances have been labeled as endocrine disruptor chemicals (EDC) as they mimic or block hormones function and therefore, disrupt the normal body physiological functions. Effects on human beings include decrease in sperm counts and quality, cryptorchidism, hypospadias, testicular and male breast cancer,impairment of ovulatory mechanism and cardiovascular system. One of the examples of these EDC is lindane, a 99% pure gamma isomer of hexachlorocyclo-hexane. Exposures to lindane are either through dermal contact, inhalation or ingestion. Acute toxicity symptoms include headache, gastrointestinal symptoms, convulsion, cyanosis and circulatory collapse. Chronic symptoms include blood disorders, convulsion and disruption of the endocrine system particularly the reproductive system. Lindane has also been anticipated as a carcinogen. The International Agency for Research in Cancer (1991) has classified lindane as Class 2B carcinogen. The United States Environmental Protection Agency (USEPA) has set a maximum contaminant level of 0.2 parts per billion (ppb) in drinking water. Acceptable daily intake (ADI) for lindane by Codex Alimentarius is 0.001 mg / kg body weight per day. Due to its endocrine disruptor characteristic and carcinogen effects, there is a need for a rapid elimination of lindane usage in the pharmaceutical, veterinary and agricultural today. We also need an effective delivery of education programme about the risk of lindane, emphasizing the protection of exposed groups of children, indigenous people and workers.
format Article
author Rozita, H.,
Hasni, M.J,
spellingShingle Rozita, H.,
Hasni, M.J,
Effects of lindane as an endocrine disruptor chemical on human health
author_facet Rozita, H.,
Hasni, M.J,
author_sort Rozita, H.,
title Effects of lindane as an endocrine disruptor chemical on human health
title_short Effects of lindane as an endocrine disruptor chemical on human health
title_full Effects of lindane as an endocrine disruptor chemical on human health
title_fullStr Effects of lindane as an endocrine disruptor chemical on human health
title_full_unstemmed Effects of lindane as an endocrine disruptor chemical on human health
title_sort effects of lindane as an endocrine disruptor chemical on human health
publisher Department Of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia
publishDate 2005
url http://journalarticle.ukm.my/4457/1/vol11-02ayiesah.pdf
http://journalarticle.ukm.my/4457/
http://www.communityhealthjournal.org/detailarticle.asp?id=340&issue=Vol11(1):2005
_version_ 1643736085430272000
score 13.160551